Skip to main content
Total Market Cap: $43,730,586,646 Volume (24h): $739,348,100

Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc. (TBP) logo
Rank 67
About

Tetra works with drug regulators to conduct cannabinoid-based research and development. Through several subsidiaries and clinical trial programmes, they aim to combine traditional medicinal cannabis with scientific validation. The North America-based company also has a patent (PPP001) for devices aimed at reducing drug abuse and treating chronic pain.

Website
$0.1596
USD
-2.44%
Market cap
$33,819,634
Total volume
$47,581
Shares outstanding
211,969,411
Rank 67
Website
About

Tetra works with drug regulators to conduct cannabinoid-based research and development. Through several subsidiaries and clinical trial programmes, they aim to combine traditional medicinal cannabis with scientific validation. The North America-based company also has a patent (PPP001) for devices aimed at reducing drug abuse and treating chronic pain.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
TSXV
TBP
$32,974
69.3%
$0.1596
OTC
TBPMF
Total volume
$14,607
30.7%
Stock price
$0.1539
Chart
Social media
Tweets by @TetraBioPharma
Tetra Bio-Pharma Inc.

Share widget

Copy widget code
Subscribe to our newsletter